ClearFlow Revenue and Competitors
Estimated Revenue & Valuation
- ClearFlow's estimated annual revenue is currently $3.4M per year.
- ClearFlow received $7.0M in venture funding in March 2018.
- ClearFlow's estimated revenue per employee is $125,500
- ClearFlow's total funding is $40.7M.
Employee Data
- ClearFlow has 27 Employees.
- ClearFlow grew their employee count by -37% last year.
ClearFlow's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Finance | Reveal Email/Phone |
2 | VP Engineering & Operations | Reveal Email/Phone |
3 | Director Finance | Reveal Email/Phone |
4 | Director Clinical Training and Education | Reveal Email/Phone |
5 | Sales & Marketing Manager | Reveal Email/Phone |
6 | US Field Trainer/South Central Territory Manager | Reveal Email/Phone |
7 | Quality Improvement Manager | Reveal Email/Phone |
8 | Senior Clinical Education Manager | Reveal Email/Phone |
9 | Senior Analyst, Finance & Accounting | Reveal Email/Phone |
10 | R&D Technician | Reveal Email/Phone |
ClearFlow Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.3M | 92 | 100% | N/A | N/A |
What Is ClearFlow?
ClearFlow, Inc. (formerly Clear Catheter Systems, Inc.) is pioneering clearable catheter systems to solve the clinical problems caused by internally obstructed medical tubes. Our platform of catheter systems enable caregivers to actively clear internal obstructions to ensure these critical tubes perform optimally. The company's lead product is the PleuraFlow® Active Clearance Technology® (ACT) System, for chest tubes. Chest tubes are used in all heart and lung surgery procedures, and frequently become obstructed by blood clots. When these tubes fail, fluid that needs to be evacuated is retained, which can lead to additional complications and a significant increase in the cost of care. By preventing chest tube failure, PleuraFlow enables caregivers to manage postoperative bleeding more safely, reliably, and efficiently. The company has a pipeline of products based on its proprietary Active Clearance Technology to prevent tube failure in other medical market segments, including urinary, gastrointestinal, and for standard surgical drains.
keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Information Security,Medical Devices,Pharmaceuticals,Security
$40.7M
Total Funding
27
Number of Employees
$3.4M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ClearFlow News
Out now for your listening pleasure, this two-tracker begins with its title track, Glass, which presents a crystal clear flow.
The recently published report provides an elaborated market research study about the Anionic Flocculant market professional survey report ...
ANAHEIM, Calif,--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its ...
ANAHEIM, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive ...
Getinge (PINK:GETI B) subsidiary Maquet Medical said it inked a pair of exclusive U.S. marketing deals for ClearFlow’s PleuraFlow chest-drainage system and InterValve’s V8 balloon catheter. Maquet is slated to begin selling ClearFlow’s PleuraFlow active clearance technology during the 1st quart ...
Other Companies in Anaheim
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.7M | 27 | -18% | N/A |
#2 | $2.7M | 27 | 4% | N/A |
#3 | $4.8M | 28 | -3% | N/A |
#4 | $7M | 28 | 0% | N/A |
#5 | $5.9M | 28 | -12% | N/A |
ClearFlow Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-03-01 | $7.0M | Undisclosed | Article |